Ameriprise
SRNE

Ameriprise’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ameriprise’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-92,656
Closed -$82K – 4075
2022
Q4 		$82K Sell
92,656
-3,851
-4% -$5.11K ﹤0.01% 3832
2022
Q3 		$152K Sell
96,507
-481
-0.5% -$1.09K ﹤0.01% 3751
2022
Q2 		$195K Buy
96,988
+21,397
+28% +$37K ﹤0.01% 3691
2022
Q1 		$176K Sell
75,591
-4,410
-6% -$13.8K ﹤0.01% 3778
2021
Q4 		$372K Sell
80,001
-13,823
-15% -$85.8K ﹤0.01% 3608
2021
Q3 		$716K Buy
93,824
+363
+0.4% +$3.08K ﹤0.01% 3285
2021
Q2 		$881K Buy
93,461
+11,895
+15% +$94.7K ﹤0.01% 3270
2021
Q1 		$674K Buy
81,566
+9,885
+14% +$104K ﹤0.01% 3297
2020
Q4 		$489K Sell
71,681
-8,400
-10% -$67.5K ﹤0.01% 3354
2020
Q3 		$893K Buy
80,081
+15,400
+24% +$141K ﹤0.01% 3018
2020
Q2 		$406K Buy
64,681
+5
+0% +$19 ﹤0.01% 3263
2020
Q1 		$119K Buy
+64,676
New +$186K ﹤0.01% 3519
2019
Q3 		– Sell
-12,580
Closed -$34K – 3789
2019
Q2 		$34K Sell
12,580
-90
-0.7% -$324 ﹤0.01% 3697
2019
Q1 		$60K Sell
12,670
-310
-2% -$813 ﹤0.01% 3649
2018
Q4 		$31K Sell
12,980
-6,350
-33% -$20.7K ﹤0.01% 3585
2018
Q3 		$85K Sell
19,330
-200
-1% -$1.11K ﹤0.01% 3633
2018
Q2 		$141K Buy
+19,530
New +$133K ﹤0.01% 3538
2015
Q3 		– Sell
-102,301
Closed -$1.8M – 3981
2015
Q2 		$1.8M Buy
+102,301
New +$1.31M ﹤0.01% 2829

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Ameriprise's SRNE Position: Q1 2023 in Review

Ameriprise sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 92,656 shares — an estimated $82K sold.

Ameriprise first reported a position in SRNE in Q2 2015 and held it in 18 quarters. The position peaked at $1.8M in Q2 2015. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Ameriprise reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Ameriprise sold 92,656 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $82K.
  • Ameriprise first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 18 quarters.
  • Ameriprise's Sorrento Therapeutics, Inc. position peaked at $1.8M in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.